Digestive Diseases and Sciences

, Volume 56, Issue 6, pp 1707–1717 | Cite as

Smoking and Barrett’s Esophagus in Women Who Undergo Upper Endoscopy

  • Brian C. Jacobson
  • Edward L. Giovannucci
  • Charles S. Fuchs
Original Article

Abstract

Background

Cigarette use is associated with esophageal adenocarcinoma, and cross-sectional studies suggest an association between smoking and Barrett’s esophagus.

Aims

We sought to examine prospectively the effect of smoking on the risk for Barrett’s esophagus.

Methods

This was a prospective cohort study among 20,863 women within the Nurses’ Health Study who underwent upper gastrointestinal endoscopy for any reason between 1980 and 2006. We assessed the association between smoking and pathologically-confirmed Barrett’s esophagus (n = 377). Self-reported data on smoking and potential confounding variables were collected from biennial questionnaires.

Results

Compared with women who never smoked, former smokers of 1–24 cigarettes/day had a multivariate odds ratio for Barrett’s esophagus of 1.25 (95% CI 0.99–1.59), former smokers of ≥25 cigarettes/day had a multivariate odds ratio of 1.52 (95% CI 1.04–2.22), current smokers of 1–24 cigarettes/day had a multivariate odds ratio of 0.89 (95% CI 0.54–1.45), and current smokers of ≥25 cigarettes/day had a multivariate odds ratio of 0.92 (95% CI 0.34–2.54). The risk for Barrett’s esophagus increased significantly with increasing pack-years smoked among former (P = 0.008) but not current smokers (P = 0.99), especially when considering exposure ≥25 years before index endoscopy. Results were similar among women reporting regular heartburn/acid-reflux one or more times a week, and were not accounted for by changes in weight.

Conclusions

Heavy, remote smoking is associated with an increased risk for Barrett’s esophagus. This finding suggests a long latency period between exposure and development of the disease, even after discontinuation of smoking.

Keywords

Barrett’s esophagus Smoking Cigarettes Gastroesophageal reflux GERD 

Abbreviations

BMI

Body mass index

GERD

Gastroesophageal reflux disease

SIM

Specialized intestinal metaplasia

MET

Metabolic equivalent task

CI

Confidence interval

OR

Odds ratio

References

  1. 1.
    Caldwell MT, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP. Ambulatory oesophageal bile reflux monitoring in Barrett’s oesophagus. Br J Surg. 1995;82:657–660.PubMedCrossRefGoogle Scholar
  2. 2.
    Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;111:1192–1199.PubMedCrossRefGoogle Scholar
  3. 3.
    Jankowski J, Wright N, Meltzer S, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999;154:965–973.PubMedCrossRefGoogle Scholar
  4. 4.
    Boch J, Shields H, Antonioli D, Zwas F, Sawhney R, Trier J. Distribution of cytokeratin markers in Barrett’s specialized columnar epithelium. Gastroenterology. 1997;112:760–765.PubMedCrossRefGoogle Scholar
  5. 5.
    Okamoto R, Yajima T, Yamazaki M, et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nature Med. 2002;8:1011–1017.PubMedCrossRefGoogle Scholar
  6. 6.
    Cameron A. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997;26:487–494.PubMedCrossRefGoogle Scholar
  7. 7.
    Winters C, Spurling T, Cohbanian S, et al. Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118–124.PubMedGoogle Scholar
  8. 8.
    Gerson L, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461–467.PubMedCrossRefGoogle Scholar
  9. 9.
    Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–1677.PubMedCrossRefGoogle Scholar
  10. 10.
    Cameron A, Zinsmeister A, Ballard D, Carney J. Prevalence of columnar-lined (Barrett’s) esophagus: comparison of population-based and autopsy findings. Gastroenterology. 1990;99:918–922.PubMedGoogle Scholar
  11. 11.
    O’Connor J, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus. Am J Gastroenterol. 1999;94:2037–2042.PubMedGoogle Scholar
  12. 12.
    Spechler S, Zeroogian J, Antonioli D, Wang H, Goyal R. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–1536.PubMedCrossRefGoogle Scholar
  13. 13.
    Caygill C, Reed P, McIntyre A, Hill M. The UK national barrett’s oesophagus registry: a study between two centres. Eur J Cancer Prev. 1998;7:161–163.PubMedGoogle Scholar
  14. 14.
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289.PubMedCrossRefGoogle Scholar
  15. 15.
    Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett’s oesophagus in Olmsted County, Minnesota. Gut. 2001;48:304–309.PubMedCrossRefGoogle Scholar
  16. 16.
    Devesa S, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053.PubMedCrossRefGoogle Scholar
  17. 17.
    Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett’s oesophagus: education, enthusiasm, or epidemiology? Lancet. 1997;350:933.PubMedCrossRefGoogle Scholar
  18. 18.
    van Soest E, Dieleman J, Siersema P, Sturkenboom M, Kuipers E. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54:1062–1066.PubMedCrossRefGoogle Scholar
  19. 19.
    Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett’s esophagus: an overrated risk? Gastroenterology. 1984;87:927–933.PubMedGoogle Scholar
  20. 20.
    Cameron A, Ott B, Payne W. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med. 1985;313:857–859.PubMedCrossRefGoogle Scholar
  21. 21.
    Spechler S, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285:2331–2338.PubMedCrossRefGoogle Scholar
  22. 22.
    Corey K, Schmitz S, Shaheen N. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol. 2003;98:2390–2394.PubMedCrossRefGoogle Scholar
  23. 23.
    Shaheen N, Crosby M, Bozymski E, Sandler R. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology. 2000;119:333–338.PubMedCrossRefGoogle Scholar
  24. 24.
    Murray L, Watson P, Johnston B, SLoan J, Mainie I, Gavin A. Risk of adenocarcinoma in Barrett’s esophagus: population based study. BMJ. 2003;327:534–535.PubMedCrossRefGoogle Scholar
  25. 25.
    Conio M, Blanchi S, Lapertosa G. Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol. 2003;98:1931–1939.PubMedCrossRefGoogle Scholar
  26. 26.
    Enzinger P, Mayer R. Esophageal Cancer. N Engl J Med. 2003;349:2241–2252.PubMedCrossRefGoogle Scholar
  27. 27.
    Brown LM, Silverman DT, Pottern LM, et al. Adenocarcinomas of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, an socioeconomic factors. Cancer Causes Control. 1994;5:333–340.PubMedCrossRefGoogle Scholar
  28. 28.
    Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Can Inst. 1997;89:1277–1284.CrossRefGoogle Scholar
  29. 29.
    Kabat GC, Ng SK, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 1993;4:123–132.PubMedCrossRefGoogle Scholar
  30. 30.
    Vaughan TL, Davis S, Kristal AR, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85–92.PubMedGoogle Scholar
  31. 31.
    Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control. 2001;12:721–732.PubMedCrossRefGoogle Scholar
  32. 32.
    Veugelers P, Porter G, Guernsey F, Casson A. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus. 2006;19:321–328.PubMedCrossRefGoogle Scholar
  33. 33.
    Edelstein Z, Farrow DC, Bronner M, Rosen S, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133:403–411.PubMedCrossRefGoogle Scholar
  34. 34.
    Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;116:277–285.PubMedCrossRefGoogle Scholar
  35. 35.
    Kulig M, Nocon M, Vieth M, et al. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol. 2004;57:580–589.PubMedCrossRefGoogle Scholar
  36. 36.
    Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831.PubMedCrossRefGoogle Scholar
  37. 37.
    Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL. Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol. 2009;104:834–842.PubMedCrossRefGoogle Scholar
  38. 38.
    Smith KJ, O’Brien SM, Green AC, Webb PM, Whiteman DC. Current and past smoking significantly increase risk for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:840–848.PubMedCrossRefGoogle Scholar
  39. 39.
    Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–1594.PubMedGoogle Scholar
  40. 40.
    Conio M, Filiberti R, Blanchi S, et al. Risk factors for Barrett’s esophagus: a case-control study. Int J Cancer. 2002;97:225–229.PubMedCrossRefGoogle Scholar
  41. 41.
    Kubo A, Levin T, Block G, et al. Dietary antioxidants, fruits, and vegetables and the risk of Barrett’s esophagus. Am J Gastroenterol. 2008;103:1614–1623.PubMedCrossRefGoogle Scholar
  42. 42.
    Johansson J, Hakansson HO, Mellblom L, et al. Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol. 2007;42:148–156.PubMedCrossRefGoogle Scholar
  43. 43.
    Smith KJ, O’Brien SM, Smithers BM, et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:2481–2486.PubMedCrossRefGoogle Scholar
  44. 44.
    Al-Delaimy WK, Willett WC. Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and self-reports. Cancer Epidemiol Biomarkers Prev. 2008;17:1255–1261.PubMedCrossRefGoogle Scholar
  45. 45.
    Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1:466–473.PubMedCrossRefGoogle Scholar
  46. 46.
    Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23:991–999.PubMedCrossRefGoogle Scholar
  47. 47.
    Willett WC, Sampson L. M.J. S. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65.PubMedGoogle Scholar
  48. 48.
    Jacobson B, Moy B, Colditz GA, Fuchs CS. Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med. 2008;168:1–7.CrossRefGoogle Scholar
  49. 49.
    Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–2348.PubMedCrossRefGoogle Scholar
  50. 50.
    Colditz G, Stampfer M, Willett W, Stason W, Rosner B, Hennekens CH. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126:319–325.PubMedGoogle Scholar
  51. 51.
    Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255–2260.PubMedCrossRefGoogle Scholar
  52. 52.
    Riffenburgh R. Statistics in Medicine. 2nd ed. ed. San Diego: Academic Press; 2005.Google Scholar
  53. 53.
    Adams P, Schoenborn C. Health behaviors of adults: United States, 2002-04.2006.Google Scholar
  54. 54.
    Kubo A, Levin TR, Block G, et al. Cigarette smoking and the risk of Barrett’s esophagus. Cancer Causes Control. 2009;20:303–311.PubMedCrossRefGoogle Scholar
  55. 55.
    Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841–1854.PubMedCrossRefGoogle Scholar
  56. 56.
    Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–523. doi:10.1038/ajg.2009.727. (quiz 24).PubMedCrossRefGoogle Scholar
  57. 57.
    McGrath J, McDonald J, MacDonald J. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004. doi:10.1002/14651858.CD004722.pub2.
  58. 58.
    Olliver J, Hardie L, Gong Y, et al. Risk factors, DNA damage, and disease progression in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:620–625.PubMedCrossRefGoogle Scholar
  59. 59.
    Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131:3109S–3120S.PubMedGoogle Scholar
  60. 60.
    Giovannucci E, Pollak MN, Platz EA, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev. 2000;9:345–349.PubMedGoogle Scholar
  61. 61.
    Chiuve S, Rexrode K, Spiegelman D, Logroscino G, Manson J, Rimm E. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118:947–954.PubMedCrossRefGoogle Scholar
  62. 62.
    Goldhaber S, Grodstein F, Stampfer M, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277:642–645.PubMedCrossRefGoogle Scholar
  63. 63.
    Meza R, Hazelton W, Colditz G, Moolgavkar S. Analysis of lung cancer incidence in the Nurses’ Health and the Health Professionals’ Follow-Up Studies using a multistage carcinogenesis model. Cancer Causes Control. 2008;19:317–328.PubMedCrossRefGoogle Scholar
  64. 64.
    Chan A, Tranah G, Giovannucci E, Willett W, Hunter D, Fuchs C. Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer. Int J Cancer. 2005;115:648–652.PubMedCrossRefGoogle Scholar
  65. 65.
    McGrath M, Wong J, Michaud D, Hunter D, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:815–819.PubMedCrossRefGoogle Scholar
  66. 66.
    Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149:307–316.PubMedGoogle Scholar
  67. 67.
    Kenfield S, Stampfer M, Rosner B, Colditz G. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299:2037–2047.PubMedCrossRefGoogle Scholar
  68. 68.
    Corley DA, Kubo A, Levin T, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.PubMedCrossRefGoogle Scholar
  69. 69.
    Corley DA, Kubo A, DeBoer J, Rumore GJ. Diagnosing Barrett’s esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc. 2009;69:1004–1010.PubMedCrossRefGoogle Scholar
  70. 70.
    Wang K, Sampliner R. Updated Guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.PubMedCrossRefGoogle Scholar
  71. 71.
    Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 1999;117:218–228.PubMedCrossRefGoogle Scholar
  72. 72.
    Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus. Gut. 2006;55:442.PubMedCrossRefGoogle Scholar
  73. 73.
    Kahrilas P, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–1391.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Brian C. Jacobson
    • 1
    • 2
  • Edward L. Giovannucci
    • 3
    • 4
    • 7
  • Charles S. Fuchs
    • 5
    • 6
    • 7
  1. 1.Section of Gastroenterology, Department of MedicineBoston University Medical CenterBostonUSA
  2. 2.Boston University School of MedicineBostonUSA
  3. 3.Department of EpidemiologyHarvard School of Public HealthBostonUSA
  4. 4.Department of NutritionHarvard School of Public HealthBostonUSA
  5. 5.Cancer Epidemiology ProgramDana-Farber and Harvard Cancer CenterBostonUSA
  6. 6.Department of Medical OncologyDana-Farber Cancer InstituteBostonUSA
  7. 7.Channing Laboratory, Department of MedicineBrigham and Women’s Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations